- Home
- AVAL vs MIRM Comparison
AVAL vs MIRM Comparison
Compare AVAL & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVAL
- MIRM
- Stock Information
- Founded
- AVAL 1994
- MIRM 2018
- Country
- AVAL Colombia
- MIRM United States
- Employees
- AVAL N/A
- MIRM N/A
- Industry
- AVAL Commercial Banks
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- AVAL Finance
- MIRM Health Care
- Exchange
- AVAL Nasdaq
- MIRM Nasdaq
- Market Cap
- AVAL 2.5B
- MIRM 2.1B
- IPO Year
- AVAL N/A
- MIRM 2019
- Fundamental
- Price
- AVAL $2.03
- MIRM $40.50
- Analyst Decision
- AVAL
- MIRM Strong Buy
- Analyst Count
- AVAL 0
- MIRM 13
- Target Price
- AVAL N/A
- MIRM $55.77
- AVG Volume (30 Days)
- AVAL 37.3K
- MIRM 358.8K
- Earning Date
- AVAL 11-13-2024
- MIRM 10-31-2024
- Dividend Yield
- AVAL 6.20%
- MIRM N/A
- EPS Growth
- AVAL N/A
- MIRM N/A
- EPS
- AVAL 0.00
- MIRM N/A
- Revenue
- AVAL $2,603,443,950.00
- MIRM $264,375,999.00
- Revenue This Year
- AVAL N/A
- MIRM $72.44
- Revenue Next Year
- AVAL $15.93
- MIRM $27.99
- P/E Ratio
- AVAL $21.00
- MIRM N/A
- Revenue Growth
- AVAL N/A
- MIRM 128.34
- 52 Week Low
- AVAL $1.94
- MIRM $23.14
- 52 Week High
- AVAL $2.71
- MIRM $45.23
- Technical
- Relative Strength Index (RSI)
- AVAL 45.13
- MIRM 48.81
- Support Level
- AVAL $1.94
- MIRM $40.78
- Resistance Level
- AVAL $2.09
- MIRM $42.49
- Average True Range (ATR)
- AVAL 0.06
- MIRM 1.57
- MACD
- AVAL -0.01
- MIRM -0.30
- Stochastic Oscillator
- AVAL 41.67
- MIRM 16.00
About AVAL Grupo Aval Acciones y Valores S.A. ADR (Each representing 20 preferred shares)
Grupo Aval Acciones y Valores SA is a Colombian financial services company. Its local operations consist of commercial banking (Banco de Bogota, Banco de Occidente, Banco Popular, and Banco AV Villas), pension fund management (Porvenir), and merchant banking (Corficolombiana). Outside Colombia, the company offers (via BAC Credomatic operations) consumer and credit card banking businesses in Central American countries (Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama) and Mexico. BAC Credomatic has key alliances with major credit card networks, such as Visa, MasterCard, American Express, and Diners Club.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.